Search for: "AstraZeneca, AB"
Results 81 - 92
of 92
Sorted by Relevance
|
Sort by Date
22 Jun 2015, 9:24 am
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 50 [week ending on Sunday 7 June] - Swiss claims | Italian-sounding trade marks for cosmetics | “IP litigation and Enforcement” event | Saving WiFi | Spy scandal at the EPO | Rihanna v DC Comics | KitKat trade mark | Taste trade marks in the Netherlands | Connectivity and human rights | Trade secrets, client confidentiality and privilege | 3-d printing and counterfeiting | Ericsson v Apple in the… [read post]
31 Jan 2023, 10:19 am
Moreover, not only Oxford but possibly third parties (such as other investors in ONI who may have an interest in ensuring that the Licence remains in place to ensure that ONI is not exposed to potential infringement claims) may wish to contend that it would be wrong for the English court to risk undermining ONI's business by voiding its key Licence ab initio. [read post]
23 Sep 2016, 7:12 am
See AstraZeneca AB v. [read post]
22 Dec 2010, 3:01 am
Pfizer Health AB & Anor v Schwarz Pharma AG & Ors (PatLit) US: Briefing updates – AMP v. [read post]
21 Aug 2011, 6:49 pm
Specifically, AstraZeneca AB (“Astra”) contends in a recent Request for Reconsideration of Final Agency Action submitted to the PTO that its PTE application for U.S. [read post]
5 Aug 2021, 12:12 pm
The outcome was a vacating of the district court's grant of JMOL and a lot of discussion of drug "skinny labels": GlaxoSmithKline LLC and SmithKline Beecham (Cork) Ltd. [read post]
3 Oct 2009, 12:10 am
" Astrazeneca AB v. [read post]
12 Feb 2015, 3:15 pm
Roach v. [read post]
5 Mar 2015, 5:52 am
AstraZeneca AB v. [read post]
23 Jun 2014, 12:57 pm
Gislaved Gummi AB, 178 F. 3d 257, 263–264 (4th Cir. 1999) (citing cases); Wells v. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most Americans… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
